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1  |  INTRODUC TION
Ageing changes the composition and function of the immune sys-
tem leading to greater susceptibility to infectious disease, reduced 
responses to vaccination and increased autoimmune manifesta-
tions in older individuals (Frasca et al., 2020; Goronzy & Weyand, 
2019; Linterman, 2014; Nikolich-Zugich, 2018). Whilst epidemio-
logical studies have demonstrated that infectious diseases cause 
increased morbidity and mortality in older people, the cellular and 
molecular changes that occur within the immune system are not 
fully understood (Crooke et al., 2019). Immune responses to vacci-
nation or infection require collaborative effort from multiple types 
of immune cells. An exemplar of this multicellular collaboration is 
the generation of long-lasting immunity by the germinal centre (GC) 
reaction where B cells, CD4+ helper T cells, dendritic cells, stromal 
cells and macrophages work together to generate antibody-secret-
ing plasma cells and memory B cells that protect against re-infection 
(Silva-Cayetano & Linterman, 2020; Vinuesa et al., 2016). With age, 
the magnitude and quality of this response declines with many of the 
cellular players contributing to this impairment (Eaton et al., 2004; 
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Abstract
Ageing profoundly changes our immune system and is thought to be a driving fac-
tor in the morbidity and mortality associated with infectious disease in older people. 
We have previously shown that the impaired immunity to vaccination that occurs in 
aged individuals is partly attributed to the effect of age on T follicular helper (Tfh) cell 
formation. In this study, we examined how age intrinsically affects Tfh cell formation 
in both mice and humans. We show increased formation of Tfh precursors (pre-Tfh) 
but no associated increase in germinal centre (GC)-Tfh cells in aged mice, suggesting 
age-driven promotion of only early Tfh cell differentiation. Mechanistically, we show 
that ageing alters TCR signalling which drives expression of the Notch-associated 
transcription factor, RBPJ. Genetic or chemical modulation of RBPJ or Notch rescues 
this age-associated early Tfh cell differentiation, and increased intrinsic Notch activity 
recapitulates this phenomenon in younger mice. Our data offer mechanistic insight 
into the age-induced changes in T-cell activation that affects the differentiation and 
ultimately the function of effector T cells.
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Lefebvre et al., 2012, 2016; Lorenzo et al., 2018; Szakal et al., 1990; 
Turner	&	Mabbott,	2017a,	2017b,	2017c;	Yang	et	al.,	1996;	Zheng	
et	al.,	1997).
The formation, maintenance and function of the GC depend on 
T follicular helper (Tfh) cells, a distinct CD4+ helper T-cell subset 
that provides essential help to B cells. Though critical for generating 
appropriate B-cell responses to infection and vaccination, dysregu-
lated Tfh cell responses can occur and are associated with a variety 
of autoimmune and inflammatory disorders, many of which develop 
with increasing age. This suggests that age can impact Tfh cell de-
velopment and/or function (Blanco et al., 2016; Deng et al., 2019; 
Edner et al., 2020; Qin et al., 2018; Vinuesa et al., 2016). In mice, 
age-dependent changes in CD4+ T cells have been shown to contrib-
ute to the defective GC and antibody responses (Eaton et al., 2004; 
Lefebvre	 et	 al.,	 2016;	 Maue	 &	 Haynes,	 2009;	 Yang	 et	 al.,	 1996).	
However, the aged microenvironment also affects GC responses 
and can inhibit generation of Tfh cells (Lefebvre et al., 2012, 2016; 
Stebegg et al., 2020). In previous work, we showed that older peo-
ple have reduced numbers of Tfh cells in peripheral blood following 
influenza vaccination. This was associated with a 5-fold reduction in 
production of vaccine-specific antibodies (Stebegg et al., 2020). This 
was also seen following immunisation of older mice where reduc-
tions in GC size, titres of antigen-specific antibodies and numbers of 
GC-Tfh cells were evident (Stebegg et al., 2020). This suggested an 
altered GC-Tfh response in older individuals and that similar age-as-
sociated defects in the Tfh cell response are common between mice 
and humans. It remains unclear how age affects Tfh cell formation 
and little is known about the molecular mechanism/s that underpin 
the altered Tfh cell biology seen in older individuals.
Generation of GC-Tfh cells occurs by a multi-step process: T-cell 
priming, differentiation to Tfh precursor (pre-Tfh) cells and then fur-
ther differentiation to GC-Tfh cells (Crotty, 2019; Webb & Linterman, 
2017).	Typically,	priming	occurs	by	a	dendritic	cell	delivering	three	
key signals to a naïve T cell: ligation of the TCR by peptide-MHCII, 
co-stimulation by CD80/86 and cytokine stimulation. These signals 
converge to direct differentiation of the T cell. In human T cells, early 
Tfh cell polarisation can be replicated in vitro when naïve CD4+ T cells 
are stimulated via CD3/CD28 in the presence of TGFβ or Activin A 
with IL-12 (Locci et al., 2016; Ma et al., 2009; Schmitt et al., 2009, 
2014). Cells generated in this system have increased expression of 
CXCR5, PD-1, ICOS, MAF and BCL6, a phenotype akin to the pre-Tfh 
cells formed in vivo when later (B-cell-dependent) stages of GC-Tfh 
cell generation are blocked (Choi et al., 2011; Kerfoot et al., 2011; 
Kitano et al., 2011).
In this study, we show that ageing results in an accumulation 
of pre-Tfh cells following immunisation of aged mice. We use the 
in vitro system described above to show that this also occurs in 
human T cells from older donors. We dissect the mechanisms that 
drive this early differentiation and established that ageing alters 
early signalling events resulting in increased expression of RBPJ, a 
transcription factor essential for the Notch pathway. We show that 
RBPJ and Notch work together to promote pre-Tfh cell differentia-
tion. However, whilst Notch activity is required, it is the age-driven 
increase in RBPJ expression that drives early Tfh cell differentiation.
2  |  RESULTS
2.1  |  Increased pre-Tfh cells following 
immunisation of older mice
In order to look at the effect of age on early Tfh cell differentiation 
in vivo, we first sought to determine the characteristics of pre-Tfh 
cells to enable their identification following immunisation. Though 
often described in the literature, identification/characterisation 
of pre-Tfh cells is less clear (Krishnaswamy et al., 2018; Ma et al., 
2012; Read et al., 2016; Song & Craft, 2019). The expression of 
the Tfh cell markers CXCR5 and PD-1 varies depending upon the 
location of the T cell; Tfh cells within the GC express the highest 
levels of CXCR5 and PD-1 whilst the pre-Tfh cells (found outside 
the follicle) express intermediate levels (Shulman et al., 2013). Bcl6 
is upregulated early in all activated T cells, and its continued ex-
pression is required for the maintenance of both the pre-Tfh and 
GC-Tfh cells, whilst SAP is essential for maintaining the cognate 
T-cell–B-cell interactions required only for full GC-Tfh cell dif-
ferentiation (Choi et al., 2011; Kerfoot et al., 2011; Kitano et al., 
2011). Consistent with this, in mice with Bcl6-deficient T cells, 
neither CXCR5intPD-1low/int pre-Tfh nor CXCR5highPD-1high GC-Tfh 
cells form after influenza A infection (Figure 1a–c). In contrast, 
CXCR5intPD-1low/int pre-Tfh cells are present in SAP-deficient 
F I G U R E  1 Age	promotes	pre-Tfh	cell	differentiation	in	mice.	Representative	flow	plots	showing	CXCR5	and	PD-1	expression	on	CD4+ 
cells isolated from draining lymph nodes of Bcl6 fl/flCd4+/+ and Bcl6 fl/flCd4cre/+ mice on day 14 postinfluenza A virus infection (a) and graphs 
showing percentage of pre-Tfh (b; CXCR5+PD-1low/int) and GC-Tfh cells (c; CXCR5hiPD-1+). Representative flow plots showing CXCR5 and 
PD-1 expression on CD4+ cells isolated from draining lymph nodes of Wt and Sh2d1a−/− mice on day 14 postinfluenza A virus infection (d) 
and graphs showing percentage of pre-Tfh (e) and GC-Tfh (f) cells. Representative flow plots showing CXCR5 and PD-1 expression on CD4+ 
T cells from inguinal lymph nodes in unimmunised 8- to 12-week-old and >85-week-old mice (g). Flow plots showing the pre-Tfh and GC-Tfh 
cells	present	in	draining	lymph	nodes	of	8-	to	12-week-old	and	>85-week-old	C57Bl/6	mice	on	day	6	postinfluenza	A	virus	infection	(h).	
Percentages of pre-Tfh cells (i) and GC-Tfh cells (j), numbers of pre-Tfh (k), GC-Tfh cells (l) and ratio of pre-Tfh to GC-Tfh cell number (m) in 
draining lymph nodes of 8- to 12-week-old and >85-week-old mice on day 6 postinfection. Percentages of naïve/effector (n), pre-Tfh (o) and 
GC-Tfh (P) CD4+ T cells expressing Bcl6 of draining lymph nodes from 8- to 12-week-old and >85-week-old mice on day 6 postinfection. 
Each symbol is representative of an independent biological replicate, and the height of the bar represents the mean. Statistics were 
calculated using Mann–Whitney U test *p < 0.05, **p < 0.005, ***p < 0.0005
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mice after infection, but CXCR5highPD-1high GC-Tfh cells do not 
form (Figure 1d–f). We then used these criteria to identify pre-
Tfh cells and GC-Tfh cells in younger adult (8–12 weeks) and aged 
(>85 weeks) mice. In unimmunised adult and aged mice, CD4+ T 
cells do not express CXCR5 or PD-1 (Figure 1g), but 6 days after 
influenza A infection, there was a marked accumulation of pre-Tfh 
cells in aged mice (Figure 1h, i) but no accumulation of GC-Tfh cells 
(Figure 1h, j) compared with younger adult mice. Since aged mice 
are lymphopenic, the increased proportion of cells that had differ-
entiated into pre-Tfh cells meant there was an equivalent number 
of pre-Tfh cells in adult and aged mice (Figure 1k), but a significant 
drop in the numbers of GC-Tfh cells in aged mice (Figure 1l). This 
indicates that pre-Tfh cell formation is intact in aged mice, but that 
there is a block in the second phase of Tfh cell differentiation (pre-
Tfh to GC-Tfh). Concordant with this hypothesis, the ratio of GC-
Tfh/pre-Tfh cells was compromised in older animals (Figure 1m). 
Analysis of Bcl6 expression in naïve/effector (Figure 1n), pre-Tfh 
(Figure 1o) and GC-Tfh (Figure 1p) cells confirmed their differentia-
tion status with Bcl6 expression increased in pre-Tfh and highest 
in GC-Tfh cells. Interestingly, the GC-Tfh cells formed in older mice 
had reduced expression of Bcl6 (Figure 1p). Using a different im-
munisation strategy that enabled identification of antigen-specific 
T cells responding directly to challenge, we were able to confirm 
that ageing promotes antigen-specific pre-Tfh cell differentiation. 
Mice were immunised with 1W1K-NP in alum and the differentia-
tion of total and 1W1K-IAb binding T cells assessed. GCs were es-
tablished	by	day	10	postimmunisation	but	few	were	seen	on	day	7	
when T cells were analysed, ensuring that the T cells have not yet 
entered the GC (Figure S1A). In aged mice, the percentage of both 
the total (Figure S1B, C) and antigen-specific pre-Tfh cells were in-
creased (Figure S1E, F), but there was no corresponding increase in 
the percentage of antigen-specific GC-Tfh cells (Figure S1E, G). This 
demonstrates that pre-Tfh cells are newly generated in response 
to the immunisation, and their differentiation is increased in aged 
mice. However, there is no such increase in the percentage of GC-
Tfh cells, and combining this with the lymphopenia seen in aged 
mice, there will be very few GC-Tfh in aged mice that can provide 
help to GC B cells. Since many of the cellular players involved in 
pre-Tfh cell differentiation are susceptible to age-driven changes, 
we turned to an in vitro system where pre-Tfh cell differentiation 
can be assessed in the complete absence of other accessory cells.
2.2  |  Naïve CD4+ T cells from older donors initiate 
cytokine-independent pre-Tfh cell differentiation
To determine whether age also affected human pre-Tfh cell forma-
tion, we used an established model of pre-Tfh cell differentiation 
(Locci et al., 2016; Ma et al., 2009; Schmitt et al., 2009, 2014). This 
in vitro system enabled us to look at the effects of ageing on human 
T cells in the absence of other cell types, thereby allowing the T-cell-
intrinsic effects of ageing to be directly assessed. Human naïve T cells 
were	flow-sorted	from	peripheral	blood	using	CD45RA	and	CD27	as	
markers	of	naivety.	Inclusion	of	CD27	enabled	exclusion	of	T	effec-
tor memory (TEMRA) cells which increase with age and re-express 
CD45RA (Figure S2A). Consistent with their naivety, we found age-
associated decreases in the frequency of CD45RA+CD27+CD4+ T 
cells (Figure S2B). There was no difference in the expression of CD28 
(Figure S2C), which has been previously noted on CD45RA+CD4+ T 
cells, possibly reflecting decreased expression by CD45RA+CD27− 
TEMRA cells (Weng et al., 2009). Naïve CD4+ T cells were purified 
from	 younger	 (17–39	 years)	 and	 older	 (60–76	 years)	 donors	 and	
stimulated via CD3/CD28 in the presence or absence of the Tfh-
polarising cytokines, IL-12 and TGFβ. The expression of the Tfh cell 
surface receptors CXCR5 and PD-1 was assessed daily and was evi-
dent on day 3 of activation (Figure S2D). Surprisingly, naïve CD4+ T 
cells from older donors generated CXCR5+PD-1+ pre-Tfh cells in the 
absence of Tfh-polarising cytokines (Figure 2a, b, Figure S2D) rep-
licating what had been observed in aged mice, providing a valuable 
model to address this age-dependent change in the human immune 
system. In contrast, CXCR5+PD-1+ pre-Tfh cells from younger donors 
could only be induced if IL-12 and TGFβ were present (Figure 2a–c, 
Figure S2D). When ICOS was used as a marker for pre-Tfh cells 
instead of PD-1, a similar effect of age on early Tfh cell differen-
tiation was seen (Figure S2E). The pre-Tfh status of the cells gener-
ated (either cytokine- or age-induced) was confirmed by the lack of 
downregulation	of	CCR7	and	lack	of	induction	of	CD57	(Figure	S2F),	
features of fully differentiated human Tfh cells found within GCs 
(Wong et al., 2015). The activation of cells from older donors in the 
presence of neutralising antibodies to Activin A, IL-12 and TGFβ had 
no effect on pre-Tfh cell differentiation (Figure 2d), confirming that 
this age-associated increase in pre-Tfh cell differentiation occurs 
independently of the “classic” Tfh-polarising cytokines. Since the 
T-cell cytokines, IL-21 and IL-2, can affect Tfh cell differentiation, we 
F I G U R E  2 Age	promotes	pre-Tfh	cell	differentiation	in	humans.	Flow	plots	showing	the	frequency	of	CXCR5+PD-1+ cells amongst CD4+ 
following 4 days in vitro activation of naïve CD4+	T	cells	taken	from	younger	(17–39	yrs)	and	older	(>60	yrs)	donors	in	the	presence/absence	
IL-12 and TGFβ (a). Percentage of CXCR5+PD-1+ following activation of naïve CD4+ T cells from younger and older donors in the absence 
(b) or presence (c) of IL-12 and TGFβ. Percentage of CXCR5+PD1+ cells following activation of naïve CD4+ T cells from older donors with 
or without neutralising antibodies to IL-12, Activin A and TGFβ (d). Bar graphs showing percentage of cells expressing pSTAT3 (e, f), and 
pSTAT5 (g, h) on day 3 of culture in presence/absence of IL-12 and TGFβ in donors of the indicated ages. RT-PCR determination MAF (i), BCL6 
(j), FOXP3 (k) and CXCL13 (l) following 4 days activation of naïve CD4+ T cells from younger and older donors in the absence of polarising 
cytokines. Flow plots (m-o) and bar graphs (n-o) showing percentage of IFNγ and IL-21 expressing cells following PMA and ionomycin 
mediated restimulation after 4 days in vitro culture of naïve CD4+ T cells from younger and older donors in the absence of IL-12 and TGFβ (m-
o). Bar graph showing levels of IgG produced by B cells following co-culture with CD4+ T cells from day four cultures from young and older 
donors, in the presence/absence of Tfh-polarising cytokines (p). Each symbol is representative of an independent biological replicate, and 
the height of the bar represents the mean. Statistics were calculated using Mann–Whitney U test *p < 0.05, **p < 0.005, ***p < 0.0005
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also examined expression of pSTAT3 and pSTAT5 during culture. As 
expected, pSTAT3 was increased in cultures with exogenous IL-12 
and TGFβ (Figure 2e) but we found no evidence for age-driven de-
crease/increase in STAT3 (Figure 2f) or STAT5 (Figure 2h) activation, 
suggesting the phenotype was not driven by IL-21 or IL-2.
To determine whether age-driven pre-Tfh phenotype extends 
beyond CXCR5 and PD-1 expression, we assessed the expression 
of Tfh cell-associated transcription factors and cytokines: T cells 
from older donors had increased expression of the early Tfh cell 
promoting transcription factor, MAF (Figure 2i), but no age-in-
duced change in the expression of BCL6 (Figure 2j)—a transcrip-
tion factor associated with established Tfh cells—confirming the 
early pre-Tfh-like phenotype of these cells. There was no age-de-
pendent increase in FOXP3 expression, indicating these cells were 
not T follicular regulatory cells (Figure 2k) which have been shown 
to accumulate in aged mice (Sage et al., 2015). T cells from older 
donors had increased expression of Tfh-associated secreted ef-
fectors CXCL13 (Figure 2l) and IL-21 (Figure 2m, n), but no increase 
in the Th1-associated cytokine IFNγ (Figure 2m, o). The absence of 
increased IFNγ suggests altered differentiation of aged T cells to 
pre-Tfh cells rather than an overall increase in T-cell activation. To 
confirm this finding, we analysed the expression of key transcrip-
tion	factors	and	cytokines	that	define	Th1,	Th2,	Th17	and	Tfh	cells	
by RNA-Seq. Naïve CD4+ T cells from younger and older donors 
were stimulated via CD3/CD28 in the absence of the polarising 
cytokines and gene expression determined 3 days later. The Tfh-
signature molecules MAF and IL21 both showed increased expres-
sion in aged T cells (Figure S3A). In contrast, the expression of Th1 
(TBX21 and IFNG; Figure S3B)-, Th2 (GATA3 and IL4; Figure S3C)- 
and	Th17	(RORC and IL17; Figure S3D)-associated transcripts were 
unaffected by the age. Pre-Tfh cells generated from older donors 
in the absence of IL-12 and TGFβ were able to support antibody 
production in T-cell:B-cell co-cultures, indicating they are func-
tional Tfh cells. These cytokine-independent pre-Tfh cells from 
older donors performed as well as cytokine-induced pre-Tfh cells 
generated from younger donors in terms of B-cell helper function 
(Figure 2p). Together, these data indicate that the activation of 
naïve T cells from older donors results in increased proportion of 
functional pre-Tfh cells in the absence of the polarising cytokines 
required by cells from younger donors.
2.3  |  Increased expression of CXCR5 following 
activation of naïve CD4+ cells from older donors
The in vitro system of pre-Tfh cell differentiation provides a valuable 
tool to look at early events occurring in this pathway enabling us to 
ask why cells from older donors had increased pre-Tfh cell differ-
entiation. First, we looked at the effect of age on naïve CD4+ T-cell 
apoptosis and cell cycle and established that neither were altered 
with age (Figure 3a–e). Naïve T cells were then labelled with cell-
trace-violet and the expression of CXCR5 and PD-1 following CD3/
CD28 activation analysed. Cells from older donors had increased 
expression of CXCR5 compared with younger donors, and this was 
evident at the first cell division (Figure 3f, g). In contrast, age had 
less effect on PD-1 expression (Figure 3h, i). Early upregulation of 
CXCR5 in T cells from older donors suggested differences in the way 
naïve CD4+ T cells perceive and/or respond to early T-cell priming 
events. Previous work has shown alterations in the signalling path-
ways of T cells from older people following TCR activation, including 
increased phosphorylation of Lck, Akt and p85, and reduced SHP-1 
phosphorylation (Kim et al., 2018; Le Page et al., 2018). Since the 
quantity and quality of TCR stimulation can alter Tfh cell differen-
tiation (Fazilleau et al., 2009; Tubo et al., 2013), we hypothesised 
that age-related changes in TCR activation may contribute to early 
CXCR5 expression and pre-Tfh cell differentiation. To investigate 
this, we looked at key pathways downstream of CD3/CD28 activa-
tion. We found that cells from older donors had an increased Ca2+ 
flux	(Figure	4a,	b),	no	changes	in	CD247	(CD3	zeta-chain;	Figure	4c,	
f) or ERK phosphorylation (Figure 4d, g) but reduced phosphoryl-
ated ribosomal protein S6 (Figure 4e, h) immediately after CD3/
CD28 co-stimulation. We looked at activation-induced expression 
of IRF4, a transcription factor whose expression is proportional to 
the	 intensity	of	TCR	signalling	 (Iwata	et	al.,	2017;	Krishnamoorthy	
et	al.,	2017;	Man	et	al.,	2013).	At	20	hrs	post-CD3/CD28	stimulation,	
CD4+ cells from older donors had both an increase in the propor-
tion of cell expression IRF4 and an increase in the levels of IRF4 ex-
pressed (Figure 4i–k). To understand whether similar age-dependent 
changes occur in murine T cells, we repeated this experiment using 
naïve T cells (flow sorted as CD62L+CD44−) from young and aged 
mice and saw a similar increase in IRF4 expression following activa-
tion (Figure 4l–n). Together with published data (Kim et al., 2018; 
Le Page et al., 2018; Li et al., 2012), these results show that ageing 
alters signals transmitted after CD3/28 activation that likely contrib-
ute to their altered differentiation.
2.4  |  Age-induced CXCR5 expression is driven 
by the transcription factor RBPJ
To further investigate the activation-induced molecular changes in 
aged T cells, we also analysed gene expression by RNA sequencing. 
Naïve CD4+ T cells from younger and older donors were stimulated 
via CD3/CD28 in the presence/absence of the polarising cytokines 
and gene expression determined 3 days later. In T cells from younger 
donors, the expression of 239 genes was changed by the addition of 
Tfh-polarising cytokines, whilst 121 transcripts were differentially 
expressed between younger and older donors when T cells were ac-
tivated in the absence of these cytokines (Figure 5a). The 34 genes 
common between these two lists were potential candidates for sup-
porting cytokine-independent pre-Tfh cell formation seen in older 
donors (Figure 5a). The transcription factor RBPJ was an exemplar of 
this gene expression pattern, associated with cytokine-dependent 
pre-Tfh cell formation in younger, and with cytokine-independent Tfh 
formation in older donors (Figure 5b). Since CXCR5 expression was 
measured by flow on cultures used to generate RNA-Seq libraries, 
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we were able to determine whether the expression of CXCR5 pro-
tein correlated with RBPJ expression. We found a strong correla-
tion for both CXCR5 mRNA and protein with RBPJ (Figure 5c, d). 
Furthermore, the age-induced increase in RBPJ expression occurred 
by day 2, a timepoint where there is little CXCR5 expression is seen, 
establishing that RBPJ expression precedes that of CXCR5 (Figure 
S4A). To determine whether RBPJ is required for CXCR5 expression, 
we used short hairpin (sh)RNA to inhibit RBPJ expression follow-
ing activation of naïve T cells from older donors. ShRNA-mediated 
knockdown of RBPJ resulted in >40% reduction in the expression 
of RBPJ (Figure 5e) and was associated with a reduction in CXCR5 
(Figure 5f, g) but not PD-1 (Figure 5f, h) expression relative to that 
seen in cells given control shScr lentivirus (Figure 5e–h). Consistent 
with its role in driving pre-Tfh cell differentiation, we found shRNA-
mediated knockdown of RBPJ caused a modest reduction in IL21 but 
not Bcl6 expression (Figure 5i, j), suggesting that RBPJ is required for 
the early Tfh cell differentiation (particularly for CXCR5 expression) 
observed in cells from older donors.
Relatively little is known about the regulation of RBPJ expres-
sion. The perturbations in signalling molecules we see following acti-
vation of T cells from older donors and their increased expression of 
IRF4 led us to hypothesise that IRF4 may regulate RBPJ expression. 
Reanalysis of recently published RNA-Seq data showed that Irf4-
deficient mouse CD4+ T cells had reduced levels of Rbpj gene expres-
sion	following	activation	(Log2	FC	=	−0.89,	p = 8.62 × 10−5; (Sidwell 
et al., 2020). We re-analysed the published ATAC-Seq and ChIP-Seq 
libraries from this work to look at the potential IRF4-dependent reg-
ulation of Rbpj expression. ChIP-Seq analysis showed IRF4 binding to 
the Rbpj promoter and analysis of ATAC-seq data showed that T-cell 
activation-induced opening of the chromatin at the Rbpj promoter in 
F I G U R E  3 Effect	of	age	on	cell	cycle,	death	and	expression	of	CXCR5	and	PD-1	in	human	CD4+ T cells. Representative flow plots 
showing cell cycle analysis at 44 hr postactivation (a). Bar graphs showing percentage of cells in different stages of cell cycle: G1 (b), S (c) and 
G2	(d)	and	percentage	of	cells	positive	for	caspase	3/7	staining	(e)	48	hours	after	activation	of	naïve	CD4+ T cells from younger (clear circles) 
and	older	(red	circles)	donors.	Expression	of	CXCR5	(f,	g)	and	PD-1	(h,	i)	relative	to	CTV	dilution	72	hr	after	activation	of	naïve	CD4+ T cells 
from younger (clear circles) and older (red circles) donors. Each symbol is representative of individual values from independent donors, the 
height of the bar represents the mean, and statistics were calculated using Mann–Whitney U or Kruskal–Wallis test *p < 0.05, **p < 0.005
(a)
(b) (c) (d) (e)
(f) (g)
(h) (i)
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an IRF4-dependent manner (Figure 5i). This demonstrates that Rbpj 
expression can be regulated by IRF4 in mouse T cells, and suggests 
that increased IRF4 may contribute to increased RBPJ expression.
2.5  |  Increased RBPJ expression enables 
Notch-mediated CXCR5 expression in cells from 
older donors
RBPJ is a transcription factor that works in collaboration with Notch 
(Amsen et al., 2009; Jarriault et al., 1995; Kopan & Ilagan, 2009). 
Upon activation, surface-expressed Notch is cleaved by gamma-
secretases, releasing its intracellular domain (NICD). NICD trans-
locates to the nucleus where it binds RBPJ and other cofactors to 
regulate gene transcription (Bray, 2016). RBPJ is an essential com-
ponent of the Notch pathway, and there is little evidence to sug-
gest Notch-independent functions of RBPJ in mammalian cells 
(Bray, 2016). Previous studies have shown that deletion of Notch 
in T cells prevents Tfh cell differentiation in vivo (Auderset et al., 
2013; Dell'Aringa & Reinhardt, 2018). It is widely assumed that dur-
ing T-cell priming Notch is activated by ligands expressed on APCs 
(Amsen et al., 2009; Dell'Aringa & Reinhardt, 2018). Since there are 
no accessory cells in the in vitro system, we first determined whether 
Notch was activated during culture. We found that T-cell activation 
generated NICD and induced expression of Notch1 and Notch2 
(Figure 6a–d). However, there were no age-related changes in the 
expression of Notch or Notch cleavage (Figure 6a–d), suggesting 
that it was the age-induced increase in RBPJ expression that was 
driving pre-Tfh cell differentiation. To determine whether Notch was 
required for RBPJ-driven CXCR5 expression, we used a low dose of 
the	gamma-secretase	inhibitor,	Ly411-575,	to	partially	inhibit	Notch	
activation (Figure 6e). This dose was chosen as higher doses pre-
vented cell proliferation. As a control, we used the gamma-secretase 
inhibitor, JLK6, which lacks the ability to inhibit Notch cleavage 
(Petit	 et	 al.,	 2003).	We	 found	 that	 whilst	 Ly411-575	 could	 inhibit	
age-induced CXCR5 expression and pre-Tfh cell differentiation, 
JLK6 had no effect (Figure 6f–i). We went on to examine the expres-
sion of the Tfh-associated transcription factor BCL6, MAF, the Th1-
associated transcription factor, TBX21 and RBPJ. We found that only 
Tfh-associated transcription factors were reduced by inhibition of 
Notch cleavage (Figure 6j–m). This suggests that inhibition of Notch 
is required for RBPJ-driven pre-Tfh cell differentiation even though 
its expression and activation are unaffected by age.
To verify these findings in vivo, we adoptively transferred Eα-
specific TEα CD4+ T cells into congenically distinct hosts treated 
with	Ly411-575	on	days,	−1,	0,	1,	2	and	3	relative	to	Eα immunisation. 
Seven	days	after	immunisation,	mice	treated	with	Ly411-575	had	a	
reduced frequency of pre-Tfh but not GC-Tfh cells (Figure S4B–D). 
To ascertain that this was CD4+ T cell-intrinsic and to attempt to 
recapitulate the ageing phenotype in vivo, we looked at the effect of 
inducing activated Notch in T cells during immunisation. For this, we 
generated mice in which Notch signalling and linked GFP expression 
can be induced upon tamoxifen administration in ovalbumin-spe-
cific transgenic T cells (Murtaugh et al., 2003). In this OT-II ERT2-
cre Rosa26Stop−flox−NICD−GFP gain-of-function system, we were able to 
directly compare CXCR5 expression in T cells experiencing endoge-
nous Notch signals relative to those with increased Notch signalling 
in the same lymph node based on GFP expression (Figure 6n). T cells 
from OT-II ERT2-cre Rosa26Stop−flox−NICD−GFP mice were adoptively 
transferred into congenically distinct wild-type mice and treated 
with	tamoxifen	on	days	−1,	0,	1	and	2	relative	to	immunisation	with	
OVA-NP/Alum. Six days after immunisation 40–50% of transferred 
OT-II cells expressed GFP-NICD and these cells had increased ex-
pression of CXCR5 compared with their GFP-negative counter-
parts (Figure 6n, o). This demonstrated that Notch drives CXCR5 
expression in vivo. Despite the increase in the proportion of cells 
expressing intermediate levels of CXCR5 (associated with pre-Tfh 
cells), far fewer NICD-GFP+ cells expressed the high levels of CXCR5 
that are associated with GC-Tfh cells (Figure 6n, p). Indeed, active 
Notch increased the proportion of cells that became pre-Tfh but did 
not promote full differentiation into GC-Tfh cells (Figure 6q, r). This 
demonstrates that by enhancing the Notch pathway specifically in T 
cells, the age-associated accumulation of pre-Tfh cells can be reca-
pitulated in younger adult animals.
3  |  DISCUSSION
This study shows that ageing affects the early stages of Tfh cell 
differentiation, resulting in accumulation of pre-Tfh cells. When 
Tfh cells are identified based on positive and negative expression 
of CXCR5 only, the distinction between pre-Tfh and GC-Tfh cells 
is lost. Whilst often referred to, pre-Tfh cells are rarely identified 
and their classification remains unclear (Krishnaswamy et al., 2018; 
Lefebvre et al., 2016; Ma et al., 2012; Read et al., 2016; Song & Craft, 
2019). By using mice deficient in either Bcl6 or SAP, we were able 
to demonstrate that pre-Tfh cells can be distinguished from GC-Tfh 
cell by their lower levels of CXCR5 and PD-1 expression. We found 
an accumulation of pre-Tfh cells in aged mice following immunisa-
tion and infection. Previous studies have shown an accumulation 
F I G U R E  4 Ageing	changes	the	response	to	activation	of	human	and	murine	naïve	CD4+ T cells. Representative flow plot (a) and 
quantitation (b) of calcium flux after CD3/CD28 cross-linking induced flux in human naïve T cells taken from younger (clear circles) and 
older	(red	circles)	donors.	Representative	flow	plots	of	pCD247	(c),	pERK	(d)	and	pS6	(e)	after	CD3/CD28	cross-linking	induced	stimulation	
of human naïve T cells taken from younger (grey line) and older (red line) donors at 10 min compared with unstimulated older donors (black 
line).	Percentage	of	cells	positive	for	pCD247	(f),	pERK	(g)	and	pS6	(h)	following	10	min	of	CD3/CD28	activation	in	human	naïve	CD4+ T cells 
from younger (clear circles) and older (red circles) donors. Representative histograms and graphs showing levels of IRF4 expression in human 
naïve CD4+ T cells from younger and older donors 20 hr postactivation with CD3/CD28 (i-k). Representative histograms showing levels of 
IRF4 expression expressed 20 hr post-CD3/CD28 activation of mouse naïve CD4+ T cells purified from spleens of 8- to 12-week-old and 
>95-week-old mice 20 hr (l-n). Statistics were calculated using Mann–Whitney U test *p < 0.05
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of pre-Tfh cells in aged mice prior to immunisation (Almanan et al., 
2020; Lefebvre et al., 2016). We did not observe this and suggest 
that this difference most likely reflects different antigen load in dif-
ferent facilities. Using naive CD4+ cells from older human donors, we 
showed that ageing enables cytokine-independent pre-Tfh cell dif-
ferentiation. These data resolve the discrepancy between the many 
studies that have reported increased (Herati et al., 2014; Sage et al., 
2015; Zhou et al., 2014) and decreased Tfh differentiation in ageing 
(Lefebvre et al., 2012, 2016; Stebegg et al., 2020). The accumulation 
of pre-Tfh cells in the absence of similarly increased proportions of 
GC-Tfh cells suggests that there is a further block in Tfh cell differ-
entiation in aged mice as previously described (Lefebvre et al., 2016). 
The aim of this study was to gain mechanistic insight into why pre-
Tfh cell differentiation is affected by age.
The accumulation of pre-Tfh cells in mice suggested that early 
events in T-cell priming were affected by age. During pre-Tfh cell 
differentiation, naïve CD4+ T cells are activated (usually by dendritic 
cells) in a cytokine-rich milieu surrounded by many other different 
cell types—all of which are susceptible to age-induced changes. In 
order to establish whether age-induced pre-Tfh cell differentiation 
was cell intrinsic, we used an in vitro system where the environment 
in which naïve CD4+ T cells can be carefully controlled. We found 
that naïve CD4+ cells isolated from older donors were able to dif-
ferentiate into pre-Tfh cells in the absence of the polarising cyto-
kines usually required. These cells expressed markers indicative of 
early Tfh cell differentiation and were able to provide help to B cells 
in an in vitro assay where T cells are co-cultured with B cells. This 
correlates with the abortive Tfh cell differentiation we saw in vivo 
where early pre-Tfh cells accumulated but there was a paucity of 
fully differentiated Tfh cells. This showed that ageing intrinsically 
effects T cells, changing their requirement for cytokines to initiate/
maintain pre-Tfh cell differentiation in vitro and likely in vivo. It is 
possible that the aged environment where naïve T cells reside af-
fects their ability to respond to antigenic stimulation. Inflammaging, 
a chronic low-grade inflammation, is associated with increased age 
and	may	alter	T-cell	responses	(Fulop	et	al.,	2017).	Naïve	T	cells	also	
depend	 upon	 IL-7	 and	 tonic	 signalling	 for	 their	 long-term	 survival	
(Koenen et al., 2013). These signals may also change with advanced 
age (Nikolich-Zugich, 2018). We already know that the stromal cells 
(which	are	 the	main	 source	of	 IL-7)	 show	profound	age-associated	
changes (Becklund et al., 2016; Denton et al., 2020).
The in vitro culture system enabled us to look at early T-cell ac-
tivation and showed that CXCR5 was upregulated early and that 
TCR signalling was perturbed. This was confirmed by the increased 
expression of IRF4, a transcription factor sensitive to the intensity of 
TCR	activation	(Iwata	et	al.,	2017;	Krishnamoorthy	et	al.,	2017;	Man	
et al., 2013). Recent work has suggested that age is associated with a 
bias towards Th9 cell differentiation (Hu et al., 2019). Although our 
study did not extend to analysis of Th9 cells, the activation-induced 
increase in IRF4 expression associated with age corroborates our find-
ings. Together, these studies suggest that ageing results in a loss of 
CD4+ T cell unbiased multipotency (Hu et al., 2019). Analysis of RNA-
Seq, Chip-Seq and ATAC-seq data suggested that IRF4 drives RBPJ 
expression in T cells resulting in increased CXCR5 expression. Indeed, 
we found strong correlation between RBPJ and CXCR5 expression and 
were able to block age-driven CXCR5 expression by shRNA against 
RBPJ. Increased levels of RBPJ are seen in CD4+ and CD8+ cells with 
an exhausted phenotype (Martinez et al., 2016), symptomatic of the 
chronic TCR stimulation associated with both exhaustion and Tfh cell 
differentiation	(Baumjohann	et	al.,	2013;	Wherry	et	al.,	2007;	Wherry	
& Kurachi, 2015). Though, neither expression nor activation of Notch 
was affected by age, inhibition of Notch activation prevented age-in-
duced pre-Tfh cell differentiation. Clearly, Notch is required for RBPJ 
activity but it is the effect of age on RBPJ expression that drives pre-
Tfh cell differentiation. Though this work has, by necessity, focused 
on in vitro assays, we were able to confirm this role of Notch in vivo and 
recapitulate age-driven pre-Tfh cell differentiation in younger mice by 
increasing intrinsic Notch activity in CD4+ T cells. Previous work has 
shown that Notch is critical for Tfh cell differentiation (Auderset et al., 
2013) but the mechanism through which Notch achieves this was un-
known. Our data show that T cells can intrinsically activate Notch fol-
lowing stimulation in the absence of Notch ligands. This suggests TCR 
activation can drive accessory-cell independent Notch activation, en-
abling RBPJ to increase CXCR5 expression and initiate early Tfh cell 
differentiation.
The age-driven increase in RBPJ expression by CD4+ T cells en-
ables increased pre-Tfh cell differentiation in older subjects. This per-
turbation in T-cell differentiation fits well with other studies where T 
cells from older donors show differences in the signalling pathways 
engaged following activation (Kim et al., 2018; Le Page et al., 2018; Li 
et	al.,	2012;	Ye	et	al.,	2018).	Our	data	show	that	age-induced	changes	
in T-cell activation have profound outcomes, affecting the differenti-
ation and ultimately the function of effector T cells. Given that age is 
the biggest risk factor for poor health, this work highlights the need 
to understand the ageing immune system, especially if we want to 
develop novel interventions and therapeutics to ameliorate immune- 
and inflammation-associated diseases in older people—arguably the 
sector of the population that is most in need of such interventions.
F I G U R E  5 Role	for	transcription	factor	RBPJ	in	age-associated	CXCR5	expression	in	human	CD4+ T cells. Venn diagram summarising 
data from RNA-Seq analysis where age-induced genes are shown in red and cytokine-induced genes in white with the 34 genes present in 
both samples listed in the table (a). Bar graph showing individual values of normalised reads for RBPJ in RNA-Seq libraries in the different cell 
culture conditions indicated (b). Correlations between levels of RBPJ with expression of CXCR5 as determined by both RNA-Seq (c) and flow 
cytometry	(d)	on	the	same	samples	72	hr	postactivation.	Graphs	showing	inhibition	of	RBPJ expression by shRNA as determined by RT-PCR 
(e).	Representative	flow	cytometry	plots	showing	effect	of	shRBPJ	and	control	(shScr)	on	pre-Tfh	cell	differentiation	at	72	hr	postactivation	
(f). Graphs showing CXCR5 (g), PD-1 (h) protein expression, IL21 (i) and BCL6 (j) relative to inhibition by control lentivirus (shScr) for CD4+ 
cells	from	individual	older	donors.	ATAC-Seq	of	naïve	and	activated	(72	hr)	Wt	and	Irf4−/− mouse CD4+ T cells at Rbpj locus. IRF4 ChIP-Seq 
tracks showing site of IRF4 binding within the Rbpj locus of naïve murine CD4+ T cells (k). Each symbol is representative of individual values 
from independent donors. Statistics calculated using Mann–Whitney U test, paired test *p < 0.05, **p < 0.005, ***p < 0.0005
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4  |  E XPERIMENTAL PROCEDURES
4.1  |  Mice
OT-II TCR-Tg, ROSA26Stop-flox-NICD-GFP (Jackson laboratories), 
ERT2Cre mice, Cd4cre, Bcl6 fl/fl, Sh2d1a−/−	 mice	 (all	 on	 C57BL/6	
background)	and	C57BL/6	mice	were	bred	and	maintained	 in	the	
Babraham	 Institute	Biological	 Support	Unit,	where	C57BL/6Babr	
mice were also aged. TEα	 (Barnden	 et	 al.,	 1998)	 and	 C57BL/6	
mice were bred and maintained at INSERM Toulouse animal facil-
ity (US006). Both male and female mice were used with age- and 
sex-matched controls. No primary pathogens or additional agents 
listed in the FELASA recommendations (Mahler et al., 2014) were 
detected during health monitoring surveys of the stock holding 
rooms. Animal husbandry and experimentation complied with ex-
isting European Union and United Kingdom Home Office legisla-
tion and local standards (PPL: P4D4AF812) as detailed (Stebegg 
et al., 2020).
For Influenza A virus infection, mice were infected intranasally 
under inhalation anaesthesia with 104 plaque-forming units of in-
fluenza A/HongKong/1/1968/x31 virus. Mice were immunised 
with either Eα-OVA in Sigma Adjuvant system (SAS, from Sigma), 
1W1K-conjugate or NP-OVA (4-hydroxy-3-nitrophenylacetyl-oval-
bumin)	in	Alum.	Imject	Alum	(#77161)	was	purchased	from	Thermo	
Fisher Scientific, and NP-OVA (#N-5051–100) was purchased from 
Biosearch Technologies. The 1W1 K conjugate was generated as 
previously described (Stebegg et al., 2020).
For adoptive transfer experiments, 5 × 104 Vα2 TCR transgenic 
TEα or 1 × 105 OT-II CD4+ T cells (isolated from spleen or LNs) were 
injected via the tail vein. For tamoxifen treatment, mice were orally 
gavaged with 200 mg/kg body weight of emulsified tamoxifen in 
sunflower oil.
4.2  |  Cell purification and sorting
Leukapheresis samples (NC24) from healthy donors were obtained 
from National Health Service Blood and Transplant Service follow-
ing ethical approval (approved by the UK Health Research Authority 
[REC reference 19/NE/0060] and Babraham Institute Human Ethics 
Committee) and processed as previously described (Hill et al., 2019). 
Naïve CD4+ T cells were enriched using Magnisort Human Naive 
CD4+ T Cell Enrichment Kit and then stained with antibodies against 
CD3,	CD4,	CD27	and	CD45RA	prior	to	sorting	on	a	BD	Biosciences	
Influx cell sorter. Cells used were >99% pure as assessed by flow.
For mouse naïve CD4+ T-cell isolation, lymphocytes were iso-
lated from lymph nodes of either 8- to 12-week-old or 95- to 
102-week-old	C57BL/6	mice.	Cells	were	enriched	using	Magnisort	
Murine Naïve CD4+ T Cell Enrichment Kit and then stained with an-
tibodies against CD3, CD4, CD44 and CD62L prior to sorting on a 
BD Biosciences Aria cell sorter. Cells used were >99% pure.
4.3  |  Naïve CD4+ T-cell activation
In initial experiments, we followed the protocol previously used 
(Schmitt et al., 2014) to generate pre-Tfh cells. In subsequent ex-
periments, 1x105 flow-sorted cells were stimulated with 5.2 × 104 
anti-human CD3/CD28 activator beads in each well of a 96 round-
bottomed plates in RPMI containing L-glutamine, penicillin–strep-
tomycin, 50 μM 2-mercaptoethanol, 1 mM sodium pyruvate, 
nonessential	 amino	 acids	 and	 25	 mM	HEPES,	 pH	 7.2–7.5	 supple-
mented with 10% FCS and harvested for analysis at various times. 
The cytokines IL-12 and TGFβ (PeproTech) were added at concen-
trations of 1 ng/ml and 5 ng/ml, respectively. For neutralisation ex-
periments, cells were incubated with neutralising antibodies against 
Activin	 A	 (15	 ng/ml),	 p70	 (225	 ng/ml),	 p35	 (2.5ug/ml)	 and	 TGFβ 
(312.5 ng/ml).
For T-cell–B-cell co-culture experiments, human naïve CD4+ 
T cells were purified and activated as described above. On day 3 
of culture, cells were plated in duplicate 96 round-bottomed wells 
at 1 × 104 with 5 × 105 B cells from a young allogeneic donor. 
Supernatants were harvested on day 11 and IgG levels determine by 
sandwich ELISA using anti-human IgG to coat plates and biotinylated 
anti-human IgG to detect IgG with a standard curve generated from 
purified human IgG.
For shRNA experiments, shRNA-encoding DNA oli-
gonucleotides (custom made by Sigma) were cloned into 
the	 HpaI	 and	 XhoI	 site	 of	 the	 pLentilox3.7	 green	 fluores-
cent protein (GFP) lentiviral vector (Addgene). The targeting 
F I G U R E  6 Increased	RBPJ	expression	enables	Notch	to	drive	CXCR5	expression.	Western	blot	(a)	and	quantification	(b)	of	cleaved	
form of NICD after 48 hr of CD3/CD28 stimulation of human naïve CD4+ T cells from younger and older people. Levels of NICD relative to 
α-actin and are shown for younger and older donors (b). Surface expression of Notch 1 (c) and Notch 2 (d) as determined by flow cytometry 
following 48 hr CD3/CD28 activation of human naïve CD4+ T cells from younger (clear circles) and older (red circles) donors. Western blot 
of NICD levels after treatment of CD3/CD28-activated human naïve CD4+ T cells in the presence of a partially inhibiting dose of Ly411-
575	(e).	Effect	of	gamma-secretase	inhibitors	Ly411-575	(50	nM)	and	JLK6	(5uM;	Notch	inactive)	on	CXCR5	expression	and	pre-Tfh	cell	
differentiation of human naïve T cells from donors >60 years of age following stimulation via CD3/CD28 (f–i). The expression of MAF (j), 
BCL6 (k), RBPJ (l), TBX21	(m),	mRNA	as	determined	by	RT-PCR	72	hr	postactivation	in	the	presence	of	Ly411-575.	Representative	flow	
cytometry plots of active Notch (NICD-GFP) in transferred murine OT-II T cells taken from draining lymph nodes 6 days postimmunisation, 
and CXCR5 expression on GFP−CD4+ cells (top, grey) and GFP+CD4+ cells (lower, green; n). Graphs showing proportion of CXCR5int (o) 
and CXCR5hi (p), Pre-Tfh (q) and GC-Tfh (r) cells in either GFP+NICD+ or GFP−NICD− murine OT-II T cells. Each symbol is representative of 
individual values from independent mice or donors. Statistics calculated using Mann–Whitney U test *p < 0.05, **p < 0.005, ***p < 0.0005, 
****p < 0.0001
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sequence for human shRBPJ has been previously described (Niessen 
et al., 2008), 5’-GCATGGCACTCCCAAGATTGA; shScrambled, 
5′-GATTAGAACCCTCACGGTACG-3′.
To produce lentivirus, transfer vector, 4.2 pGagPol (packaging 
plasmid) and pEcoEnv (envelope plasmid) were transfected into 
HEK293 T cells using Lipofectamine 2000 (Thermo Fisher Scientific 
UK). Human naïve CD4+ T cells were activated for 24 hr with an-
ti-CD3/CD28 activator beads and then spin infected with LentiX 
(Clontech) concentrated viral supernatants generated by trans-
fected HEK293 T cells. T cells were assessed 2 days later.
For measurement of IRF4 expression in mouse, 1 × 105 purified 
naïve CD4+ T cells were stimulated with anti-mouse CD3/CD28 ac-
tivator beads (Thermo Fisher Scientific).
4.4  |  Flow cytometry analysis
Cells were harvested and stained with antibodies against cell surface 
antigens, CXCR5, PD-1, CD25, CD28, Notch1 and Notch2 (all antibod-
ies used are shown in Table 1). To stain for 1W1 K-specific CD4 T cells, 
cell suspensions were first pre-treated with Dasatinib (BioVision Cat 
no.	1568–100,	1:20	000)	for	10	min	at	37°C	prior	to	staining	with	a	
PE-conjugated MHC class II tetramer containing the 1W1 K peptide 
(obtained through the NIH Tetramer Core Facility; PE-coupled ‘I-A(b) 
EAWGALANKAVDKA’ and incubated for 2 hr at room temperature. 
Cells were then washed in PBS containing 2% FCS and stained with 
antibodies as described above. For intracellular staining, cells were 
first incubated with a live/dead cell dye (Thermo Fisher Scientific UK) 
for 10 min at room temperature prior to fixing and permeabilising in 
FoxP3 Fix/Perm kit (Thermo Fisher Scientific UK) and followed by 
staining for IRF4. In cell tracker experiments, cells were first stained 
with Cell-TRACE-Violet (Thermo Fisher Scientific UK) cell prolifera-
tion kit according to manufacturer's instructions. For calcium flux 
analysis, cells were first loaded with calcium indicator using the PBX 
assay kit (BD Biosciences) according to the manufacturer's instruc-
tions and then coated with anti-CD3 and anti-CD28 as described 
above. Cells were run through a BD LSR Fortessa for 30 s prior to 




facturer's instructions. For intracellular cytokine analysis, cells were 
restimulated with PMA plus ionomycin (both Sigma) for 20 hr and 
Golgi Plug (Thermo Fisher Scientific UK) added for the last 4 hr prior 
to fixing cells in BD Cytofix/Cytoperm, washing in Cytoperm buffer 
(BD Biosciences) and stained with antibodies against IFNγ and IL-12 
prior and analysed on a BD LSR Fortessa.
For stimulation to look at phosphorylated forms of signalling 
proteins, cells were either taken from 3-day cultures following 
CD3/CD28 stimulation or incubated with anti-mouse CD3 and an-
ti-mouse	CD28	abs	in	excess	at	4°C	for	20	min	prior	incubation	with	
cross-linking	anti-IgG	for	20	min	at	4°C.	Cells	were	then	placed	at	
37°C	 for	10	min	prior	 to	 fixing	with	BD	Cytofix	 (BD	Biosciences),	
then incubated with ice-cold 90% methanol for 30 min prior to stain-
ing	with	antibodies	against	pSTAT3,	pSTAT5,	pCD247,	pERK	and	pS6	
washed and analysed on a BD LSR Fortessa.
4.5  |  RNA isolation and RT-qPCR
Total RNA was extracted using RNeasy Micro kit (Qiagen), and first-
strand cDNA was synthesised on 100 ng RNA using iScript RT-PCR 
kit	 (Bio-Rad).	TaqMan	PCR	Master	Mix	 (Thermo	Fisher)	 and	SYBR	
Green PCR Master Mix kit (Applied Biosystems), with gene-specific 
primer pairs, were used as detailed in Table S1. Gene expression was 
analysed using the comparative threshold cycle (Ct) method with ei-
ther 18S and B2M (for TaqMan assays) or GAPDH and VCP	(for	SYBR	
green assays) used as the reference genes for normalisation.
4.6  |  RNA sequencing
RNA was isolated from 5 × 105	 cells	 72	 hr	 postactivation	 using	
RNeasy Micro Kit (Qiagen). 1ug of RNA from each sample was pro-
cessed using TruSeq-stranded mRNA Sequencing Kit (Illumina), 
followed by sequencing on the Illumina HiSeq2000 with about 
50 million 100 bp single-end reads per sample.
4.7  |  Bioinformatic analysis
Transcriptomic analyses were performed using the SeqMonk soft-
ware package (Babraham Institute, https://www.bioin forma tics.
babra ham.ac.uk/proje cts/seqmo nk/) after alignment of reads to the 
reference human genome GRCh38 using HISAT2. Differentially ex-
pressed genes were determined by DESeq2 using raw counts (ad-
justed p value cut-off, <0.05) and the Intensity difference test within 
the SeqMonk program.
Fastq files for published ChIP-seq and ATAC-seq datasets (GSE12 
6811) were downloaded from the short-read archive (SRA). Quality 
was assessed using FastQC (version 0.11.9; https://www.bioin forma 
tics.babra ham.ac.uk/proje cts/fastq c/), and reads were trimmed using 
Trim Galore (version 0.6.5; https://www.bioin forma tics.babra ham.
ac.uk/proje cts/trim_galor e/) with default parameters. Mapping against 
the GRCm38 mouse genome was performed using Bowtie 2 (version 
2.3.5.1) with default parameters. Reads covering the genomic region 
encompassing Rbpj were quantified and normalised to total read count 
(normalising to the largest library for ATAC-seq and ChIP-seq sepa-
rately) using SeqMonk (version 1.46.0; https://www.bioin forma tics.
babra ham.ac.uk/proje cts/seqmo nk/), before plotting using R.
4.8  |  Western Blotting
5 × 105 T cells were lysed in NP-40 lysis buffer in the presence of 
protease inhibitors and proteins resolved by SDS-PAGE, probed 
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TA B L E  1 Key	Resources	Table.	Table	showing	details	of	reagents	used	in	the	Experimental	Procedures
Reagent Source Species Identifier Clone
Antibodies—anti-human Invitrogen Anti-human 45–0037–42 OKT3
CD3-PerCPCy5.5 eBioscience Anti-human 56–0048–82 OKT4
CD4-AF700 eBioscience Anti-human 56–0049–41 RPA-T4
CD45RA-FITC BioLegend Anti-human 304106 HI100
CD27-PECy7 BioLegend Anti-human/mouse 123216 LG.3A10
CXCR5-PE BioLegend Anti-human 356904 D252D4
ICOS-APC eBioscience Anti-human 17–9948–42 ISA−3
PD−1-AF647 BioLegend Anti-human 329910 EH12.2H7
IRF4-PE BioLegend Anti-human, mouse, rat 646404 IRF4.3F4
BCL6 BD Anti-human, mouse, rat 561522 KI 12–91
CD3 BD Bioscience Anti-human 300402 UCHT1
CD28 Invitrogen Anti-human 16–0289–85 CD28.1
pCD247 Invitrogen Anti-human, mouse, rat 12–28–41 32BR45
pErk-PE BD Bioscience Anti-human 612566 20A
pS6-AF647 Cell Signalling Anti-human 48s1 s D57.2.2E
CD25-APC eBioscience Anti-human 17–0259–41 BC96
CD28 eBioscience Anti-human 302912 CD28.2
CD28 BD Pharmingen Anti-human 555726 CD28.2
CD3 BioLegend Anti-human 300401 UCHT1
IFNg eBioscience Anti-human 25–7319–41 45.B3
IL−21 eBioscience Anti-human 12–7219–42 eBIO3A3-N2
Notch1-PE BD Anti-mouse 552768 mN1A
Actin Sigma Anti-human, mouse, rat A5441 AC−15
Notch1 BD Pharmingen Anti-human 563421 MH1 N1-519
Notch2 BioLegend Anti-human 34803 MHN2-25
Activin A RnD Systems Anti-human, mouse, rat MAB3381 69403
IL−12	p70 RnD Systems Anti-human MAB219 24916
IL−12p35 Invitrogen Anti-human 14–7128–82 BT21
TGFB RnD Systems Anti-human MAB1835 1D11
pStat5-PE eBioscience Anti-human/mouse 12–9010–42 SRBCZX
pStat3-AF647 BD Pharmingen Anti-human 557815 pY705
Fc block eBioscience Anti-human 14–9161–73 N/A
Antibodies - anti-mouse
CD3-PerCPCy5.5 Invitrogen Anti-mouse 45–0031–82 145-2C11
CD4-APC Invitrogen Anti-mouse 17–0041–83 GK1.5
CD44-AF700 BioLegend Anti-mouse 103026 Im7
CD62L-PECy7 eBioscience Anti-mouse 25–0621–82 Mel14
IRF4 BioLegend Anti-human, mouse, rat 646404 IRF4.3F4
BCL6-PE BD Anti-human, mouse, rat 561522 KI 12–91
BCL6-PECy7 BD Anti-human, mouse, rat 583582 KI 12–91
CXCR5-APC BioLegend Anti-mouse 145506 L138D7
FoxP3-APC Invitrogen Anti-mouse 17–5773–82 FKJ−16S
PD−1-PECy7 BioLegend Anti-mouse 109110 RMP1-30
Va2 Invitrogen Anti-mouse 17–5812–82 20.1
CD45.1-PECy7 eBioscience Anti-mouse 25–0453–82 A20
(Continues)
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overnight with primary antibodies (1:1000 rat anti-Notch1 and 
1:10 000 mouse anti α-actin). Immunoreactive bands were visualised 
by enhanced chemiluminescence using Immobilon Western Reagent 
(Millipore Inc.) and detected with the G:Box System (Syngene).
4.9  |  Statistical analysis
Prism software (GraphPad) was used for all statistical analysis. 
Data were analysed with a two-sample unpaired (or paired, where 
appropriate) Mann–Whitney U test or Kruskal–Wallis test to com-
pare variables across groups. p values were considered significant 
when <0.05.
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